All use must comply with local regulations and ethical research standards
Some researchers report success with single-freeze protocols (reconstituting, aliquoting into single-dose volumes, and freezing once), but this is not standard practice and may affect potency unpredictably
Current literature utilizes the Cartalax TB4 BPC-157 40mg blend primarily for: Osteoarthritis & Cartilage Degradation Modeling: Investigating the simultaneous pathways of new chondrocyte formation paired with rapid structural matrix repair
TB-500, a synthetic analog of thymosin beta-4, has demonstrated benefits in modulating actin dynamics, improving cell migration, and promoting angiogenesis
The delayed-release capsule is designed to deliver this higher-potency dose to the lower gastrointestinal region, supporting tissue integrity, digestive balance, and whole-body resilience